Not only do I not see that push from inside the industry, if we rewind, we have people inside the industry saying stuff like, “Insider trading is cool, and that’s how we get information out.” And that’s the bonus of these markets, that people have an incentive to share information broadly via insider trading. I’m not making this up. There is literally an academic paper on this. So I find this very difficult to believe, because insofar as prediction markets have any value whatsoever, that value is tied specifically to insider information.
By signing up, you agree to receive recurring automated SMS marketing messages from Mashable Deals at the number provided. Msg and data rates may apply. Up to 2 messages/day. Reply STOP to opt out, HELP for help. Consent is not a condition of purchase. See our Privacy Policy and Terms of Use.
。关于这个话题，体育直播提供了深入分析
We are aware of two mistakes in our efforts to verify the signatures in the form so far. One person who was not an employee of OpenAI or Google found a bug in our verification system and signed falsely under the name "You guys are letting China Win". This was noticed and fixed in under 10 minutes, and the verification system was improved to prevent mistakes like this from happening again. We also had two people submit twice in a way that our automatic de-duplication didn't catch. We do periodic checks for this.，推荐阅读一键获取谷歌浏览器下载获取更多信息
目前，亚虹医药已与美国 FDA 就支持 APL-1702 美国上市的 Ⅲ 期临床设计达成共识，正积极筛选海外合作伙伴以推进美国临床试验申请。欧洲市场方面，APL-1702拟用于治疗HSIL患者的上市许可申请已获得欧洲药品管理局（EMA）受理，距离上市仅一步之遥。作为全球首款 HSIL 无创疗法，APL-1702 在海外市场具备稀缺性核心优势，有望凭借高等级临床证据获得溢价合作条件，实现全球权益的高价值变现。，推荐阅读爱思助手下载最新版本获取更多信息